
Meghalayan Medical Drugs And Services Limited
Founded in 2022 and headquartered in Meghalaya, India.
Founded in 2022 and headquartered in Meghalaya, India.
Meghalayan Medical Drugs And Services Limited (MMDASL) is a Public Limited State Government Company incorporated in India on 13 November 2022 (Two years and six months 7 days old ). Its registered office is in Khasi Hills, Meghalaya, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹6.19 Cr.
Sampath Pamu, Janupribalas Momin, Wolker Kharlukhi, and Five other members serve as directors at the Company.
Khasi Hills, Meghalaya, India
+91-XXXXXXXXXX
U85300ML2022SGC013895
013895
Public Limited State Government Company
13 Nov 2022
25 Sep 2024
31 Mar 2024
Unlisted
Roc Shillong
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ramkumar Sathurappan ![]() | Managing Director | 13-Nov-2022 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sampath Pamu ![]() | Director | 13-Nov-2022 | Current |
Janupribalas Momin | Nominee Director | 22-May-2024 | Current |
Wolker Kharlukhi ![]() | Nominee Director | 01-Mar-2024 | Current |
Fairnolyn Kharshiing ![]() | Nominee Director | 01-Mar-2024 | Current |
Rilynti Lyngdoh ![]() | Nominee Director | 11-Sep-2023 | Current |
Lumlang Thangkhiew ![]() | Nominee Director | 01-Sep-2023 | Current |
Enhance accessibility to Meghalayan Medical Drugs And Services's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2023, Meghalayan Medical Drugs And Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sampath Pamu is a mutual person
Sampath Pamu is a mutual person
₹61.89 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
09 Sep 2024 | Others | ₹6.19 Cr | Open |
Meghalayan Medical Drugs And Services has a workforce of 0 employees as of Oct 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Meghalayan Medical Drugs And Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meghalayan Medical Drugs And Services's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Meghalayan Medical Drugs And Services Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records.
A charge with Others amounted to Rs. 61.89 M with Charge ID 100998118 was registered on 09 Sep 2024.
Janupribalas S Momin was appointed as a Nominee Director was appointed as a Nominee Director on 22 May 2024 & has been associated with this company since 11 months 28 days .
Meghalayan Medical Drugs And Services Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Shillong.
Wolker Macdonald Kharlukhi was appointed as a Nominee Director was appointed as a Nominee Director on 01 Mar 2024 & has been associated with this company since 1 year 2 months .
Fairnolyn Verina Kharshiing was appointed as a Nominee Director was appointed as a Nominee Director on 01 Mar 2024 & has been associated with this company since 1 year 2 months .
Meghalayan Medical Drugs And Services Limited was incorporated on 13 Nov 2022.
The authorized share capital of Meghalayan Medical Drugs And Services Limited is ₹ 1.50 M and paid-up capital is ₹ 0.50 M.
Currently 8 directors are associated with Meghalayan Medical Drugs And Services Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Meghalayan Medical Drugs And Services Limited is Office Of The Mission Director Nhm Dhs Laitumkhrah, New Colony India, Shillong, Meghalaya, 793003.
The corporate identification number (CIN) of Meghalayan Medical Drugs And Services Limited is U85300ML2022SGC013895 and the company number is 013895 as per Ministry of Corporate Affairs (MCA).
As per the financial statements for fiscal Year 0, The total open charges for Meghalayan Medical Drugs And Services Limited amount to ₹ 6.19 Cr.
The most recent Balance Sheet for Meghalayan Medical Drugs And Services Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
RK
RA